WeVote
Log In

Bill

Bill

H 2430

An Act including Krabbe Disease in newborn screening

194th Legislature (2025-2026) Introduced by Colleen Garry

Massachusetts bill adds Krabbe Disease to newborn screening to enable early detection and intervention for this rare, progressive neurological disorder that typically affects infants.

Accompanied a study order, see H5234
0
WeVote Research Nonpartisan
Bill Summary · H 2430

Legislative bill overview

H 2430 proposes adding Krabbe Disease to Massachusetts's newborn screening program. Krabbe Disease is a rare, inherited lysosomal storage disorder that causes progressive neurological deterioration, typically appearing in infancy. Early detection through newborn screening could enable earlier intervention and potentially better health outcomes.

Why is this important

Krabbe Disease is severe and often fatal, with infantile-onset forms causing death by age 2-4 years. Early identification allows families to access available treatments, supportive care, and informed medical decisions. Newborn screening programs are designed to catch treatable conditions before symptoms emerge, making this expansion potentially life-altering for affected families.

Potential points of contention

  • Cost and resource allocation: Adding tests to newborn screening increases program costs; policymakers must weigh this against the rarity of Krabbe Disease (approximately 1 in 100,000-200,000 births)
  • Treatment availability and efficacy: While early detection is valuable, available treatments (hematopoietic stem cell transplantation, gene therapy) are expensive, experimental, or have limited proven efficacy depending on disease type and timing
  • Psychological burden: Screening for rare, incurable conditions may cause significant parental anxiety and psychological distress, particularly if no effective treatment options exist for some cases

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.